Amyotrophic Lateral Sclerosis Market 2019 by Type, Treatment and Diagnosis, Size, Growth and Trends by Forecast to 2023

“Amyotrophic Lateral Sclerosis Market”
This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Amyotrophic Lateral Sclerosis Market over the forecast period.

According to the United Nations, in 2017 approximately over 962 million population were aged over 60 and above globally. United Nations has also estimated that by 2050, the number of older population is likely to reach 425 million. This is likely to propel the growth of the global amyotrophic lateral sclerosis market. Factors that are likely to hamper the growth of the market is the lack of awareness regarding the treatment.

Global Amyotrophic Lateral Sclerosis Market is expected to grow at a CAGR of 7.89% during the forecast period.

Get Free Sample Copy @  

Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmental factors such as exposure to toxic or infectious agents, viruses, physical trauma, diet, and behavioral and occupational factors.

The Global Amyotrophic Lateral Sclerosis Market is majorly driven by the growing prevalence of ALS, rising older population leading to rise in the patient population. Additionally, government funding, rising programs to create awareness, and market players offering advanced products are likely to drive the market.

Key Players                                                                                                         

Some of the key players in the Amyotrophic Lateral Sclerosis market are GNT Pharma, Synthetic Biologics, Avicena Inc., Amkor Pharma, Mitsubishi Tanabe Pharma, Sanofi, and Biogen Inc., among others.


The Global Amyotrophic Lateral Sclerosis Market is segmented on the basis of type, treatment, diagnosis, and end-user.

On the basis of type, the market is segmented into Familial ALS and Sporadic ALS.

On the basis of diagnosis, the market is segmented into laboratory tests, imaging tests, and others. On the basis of diagnosis, laboratory tests are further sub-segmented into blood tests, urine tests, and thyroid functioning tests. On the basis of imaging test, it is further sub-divided into Electromyography (EMG), X-ray, and Nerve Conduction Study (NCS). 

On the basis of treatment, the market is segmented into medication, physical therapy, speech therapy, nutritional support, and breathing support. On the basis of treatment, medication is further sub-segmented into Edaravone and Riluzole.

 On the basis of end-user, the market is segmented into specialty centers, hospitals, and research centers.

Regional Analysis

Based on region, the amyotrophic lateral sclerosis market covers growth opportunities and latest trends across North America, Europe, Asia Pacific, and the Middle East and Africa. Of these, North America will lead the market during the forecast period owing to support from the government for R&D, rising pool of awareness, the existence of many leading market players, increasing incidence of hypertension, and advanced medical facilities. Canada and the USA are the largest contributors in this region. Europe will have the second largest share in the amyotrophic lateral sclerosis market during the forecast period. The UK, Germany, and France will be the largest contributors in this region. In the APAC region, the amyotrophic lateral sclerosis market is anticipated to grow rapidly owing to the rapidly expanding healthcare infrastructure, increasing the incidence of ALS, the presence of the growing economies mainly India and China, and increasing setups of R&D centers. South Korea, Japan, and Australia are the other vital country-specific markets here. On the other hand, the amyotrophic lateral sclerosis market in the Middle East and Africa will have the smallest share owing to poor countries, inadequate healthcare facilities, lack of education, medical facilities having low standard, lack of awareness and lack of advanced and innovative medical facilities.

Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @  

Detailed Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Treatment Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

…TOC Continued!

Send an Enquiry @


About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India